Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shankar J Chinta

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 29, 2016
Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's DiseaseSubramanian Rajagopalan, Anand Rane, Shankar J Chinta, et al.
Neuroscience Letters|April 29, 2006
In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's diseaseShankar J Chinta, Subramanian Rajagopalan, D Allan Butterfield, et al.
Neuroscience Letters|October 5, 2010
Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivoShankar J Chinta, Jyothi K Mallajosyula, Anand Rane, et al.
Plos One|January 18, 2013
Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's diseaseChristopher A Lieu, Shankar J Chinta, Anand Rane, et al.
Micropublication Biology|June 19, 2020
Kavain suppresses human Aβ-induced paralysis in <i>C. elegans</i>Manish Chamoli, Shankar J Chinta, Julie K Andersen, et al.
Neurobiology of Disease|May 18, 2016
Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alphaAlmas Siddiqui, Anand Rane, Subramanian Rajagopalan, et al.
Antioxidants & Redox Signaling|March 18, 2009
A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's diseaseDonna W Lee, Deepinder Kaur, Shankar J Chinta, et al.
Neurotoxicology|February 23, 2018
Hsp90 Co-chaperone p23 contributes to dopaminergic mitochondrial stress via stabilization of PHD2: Implications for Parkinson's diseaseAnand Rane, Subramanian Rajagopalan, Manuj Ahuja, et al.
Archives of Biochemistry and Biophysics|March 9, 2002
Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbitalSudarshan C Upadhya, Shankar J Chinta, Harish V Pai, et al.
Experimental Gerontology|October 5, 2014
Cellular senescence and the aging brainShankar J Chinta, Georgia Woods, Anand Rane, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 29, 2016
Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's DiseaseSubramanian Rajagopalan, Anand Rane, Shankar J Chinta, et al.
Neuroscience Letters|April 29, 2006
In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's diseaseShankar J Chinta, Subramanian Rajagopalan, D Allan Butterfield, et al.
Neuroscience Letters|October 5, 2010
Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivoShankar J Chinta, Jyothi K Mallajosyula, Anand Rane, et al.
Plos One|January 18, 2013
Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's diseaseChristopher A Lieu, Shankar J Chinta, Anand Rane, et al.
Micropublication Biology|June 19, 2020
Kavain suppresses human Aβ-induced paralysis in <i>C. elegans</i>Manish Chamoli, Shankar J Chinta, Julie K Andersen, et al.
Neurobiology of Disease|May 18, 2016
Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alphaAlmas Siddiqui, Anand Rane, Subramanian Rajagopalan, et al.
Antioxidants & Redox Signaling|March 18, 2009
A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's diseaseDonna W Lee, Deepinder Kaur, Shankar J Chinta, et al.
Neurotoxicology|February 23, 2018
Hsp90 Co-chaperone p23 contributes to dopaminergic mitochondrial stress via stabilization of PHD2: Implications for Parkinson's diseaseAnand Rane, Subramanian Rajagopalan, Manuj Ahuja, et al.
Archives of Biochemistry and Biophysics|March 9, 2002
Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbitalSudarshan C Upadhya, Shankar J Chinta, Harish V Pai, et al.
Experimental Gerontology|October 5, 2014
Cellular senescence and the aging brainShankar J Chinta, Georgia Woods, Anand Rane, et al.
Pageof 5